SOURCES:
Barbara Giesser, MD, neurologist, MS specialist, Pacific Neuroscience Institute at Providence Saint John’s Health Center, Santa Monica, CA.
Gabriel Pardo, MD, director, Oklahoma Medical Research Foundation’s Multiple Sclerosis Center of Excellence, Oklahoma City.
National Multiple Sclerosis Society: “Adherence.”
Multiple Sclerosis Trust (U.K.): “When Can You Safely Stop Taking Disease Modifying Drugs?”
Journal of Neurology, Neurosurgery, and Psychiatry: “Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.”
International Journal of MS Care: “Stopping Disease-Modifying Therapy in Nonrelapsing Multiple Sclerosis.
Patient-Centered Outcomes Research Institute: “Can Some MS Patients Safely Stop Taking Medicines?”
